T. Munde et al. / Phytochemistry 91 (2013) 165–176
175
5.6. Administration of labelled precursors
(C-8), 141.0 (C-6), 145.3 (C-1’), 148.8 (C-7), 149.0 (C-5), 151.2
(C-2), 169.3 (C-1’’’), 171.5 (C-2’’’), 182.2 (C-1). Please note differ-
ent carbon atom numbering of 1a in the text and figures.
2,5,6-Trihydroxy-9-phenylphenalen-1-one (2a): HPLC (gradient
b): UV (MeCN–H2O) kmax 208, 278, 374 nm; 1H NMR (500 MHz,
acetone-d6): d 7.36 (s, 1H, H-3), 7.38–7.44 (m, 5H, H-2’ to H-6’),
7.54 (d, J = 8.2 Hz, 1H, H-8), 7.84 (s, 1H, H-4), 8.66 (d, J = 8.2 Hz,
1H, H-9); 13C NMR (125 MHz, acetone-d6): d 112.9 (C-3), 118.4
(C-3a), 120.7 (C-9b), 122.7 (C-4), 125.4 (C-9a), 126.9 (C-4’), 128.2
(C-3’/5’), 129.1 (C-2’/6’), 129.2 (C-9), 129.9 (C-6a), 130.6 (C-8),
139.0 (C-6), 144.2 (C-1’), 147.3 (C-7), 149.0 (C-5), 150.7 (C-2),
178.4 (C-1).
The administered amounts of labelled compounds were as
follows: [2-13C](S)-3-(4-hydroxyphenyl)lactic acid (3.0 mg),
[2-13C](R)-3-(4-hydroxyphenyl)lactic acid (3.0 mg), [2-13C]-3-(4-
hydroxyphenyl)pyruvic acid (3.0 mg), [2-13C]Phe (3.5 mg),
[2-13C]CA (2.7 mg), [6-13C]DAH-I (3.5 mg), [6-13C]DAH-II (3.5 mg),
and [phenyl–13C6]lachnanthocarpone 3b (2.2 mg). Compounds
were administered to W. thyrsiflora root cultures (100 ml medium)
as an ethanolic solution (1 ml) through a sterile membrane filter.
For incubation with 18O2, the conical flask containing the root cul-
ture was connected through a three-way cock to a vacuum pump
and an 18O2 reservoir. The normal atmosphere was removed from
the incubation flask under vacuum (72 mbar) and 18O2 filled from
the scaled reservoir. The incubation flask was also connected to a
tube containing NaOH for trapping metabolically formed CO2 from
cultured roots. The incubation time was 4-5 days except in the 18O2
incubation experiments (7 days) under continuous shaking
(85 rpm). The administration of radio-labelled [2,3,4, 5,6-3H]Phe
(1.5 mg, 0.37 kBq) and [U–14C]CA (1.5 mg, 0.34 kBq) in absorption
experiments was carried out under conditions otherwise identical
to experiments using stable isotope labelling.
[2,5-di-O13CH3]6-O-[(6’’-O-Allophanyl)-b-
D-glucopyranosyl]-
2,5-methoxy-7-phenylphenalen-1-one (1b): HPLC (gradient c):
UV (MeCN–H2O) kmax 201, 279, 374 nm; 1H NMR (500 MHz,
MeOH-d4): d 2.05 (dd, J = 7.7, 9.3 Hz, 1H, H-2’’), 2.97 (ddd,
J = 2.3, 5.6, 9.7 Hz, 1H, H-5’’), 3.03 (dd, J = 8.7, 9.7 Hz, 1H, H-4’’),
3.21 (dd, J = 8.7, 9.3 Hz, 1H, H-3’’), 3.45 (dd, J = 5.6, 11.9 Hz, 1H,
H-6’’a), 3.60 (dd, J = 2.3, 11.9 Hz, 1H, H-6’’b), 3.99 (s,
1
1JHÀC = 145.0 Hz, 3H, 2-O13CH3), 4.05 (s, JHÀC = 145.0 Hz, 3H, 5-
O13CH3), 5.11 (d, J = 7.7 Hz, 1H, H-1’’), 7.29 (s, 1H, H-3), 7.32
(br, 1H, H-5’), 7.38 (br, 2H, H-2’ and H-4’), 7.44 (br, 1H, H-6’),
7.50 (br, 1H, H-3’), 7.55 (d, J = 7.6 Hz, 1H, H-8), 7.86 (s, 1H, H-
4), 8.56 (d, J = 7.6 Hz, 1H, H-9); 13C NMR (125 MHz, MeOH-d4):
5.7. Extraction, purification and derivatization of compounds 1a and 2a
d
56.31
(2-18O13CH3, 1D
d
18O(13C)=À25 ppb),
56.34
Cultured roots were taken from the medium, shock-frozen by
liquid nitrogen, ground, and extracted with MeOH at room temper-
ature. The extract was evaporated to dryness (<40 °C), and the
residue subjected to liquid–liquid separation between n-
hexane-H2O, CH2Cl2–H2O and EtOAc–H2O. The organic phases
were subjected to preparative HPLC on a LiChrospher RP18 column
(2-16O13CH3), 57.73 (5-18O13CH3, 1D
d
18O(13C)=À29 ppb), 57.76
(5-16O13CH3), 62.8 (C-6’’), 71.5 (C-4’’), 74.6 (C-2’’), 77.8 (C-5’’),
78.2 (C-3’’), 103.0 (C-1’’), 115.6 (C-3), 121.4 (C-9b), 122.3 (C-4),
126.6 (C-3a), 128.0 (C-6a, C-2’, C-4’), 128.6 (C-9), 128.9 (C-6’),
129.5 (C-9a), 129.7 (C-3’), 130.3 (C-5’), 132.6 (C-8), 143.6 (C-
6), 145.8 (C-1’), 149.7 (C-7), 151.4 (C-5), 153.7 (C-2), 169.3 (C-
1’’’), 171.5 (C-2’’’), 179.2 (C-1). Please note different carbon atom
numbering of 1b in the text and figures.
(10
lm, 250 Â 10 mm). A linear gradient MeCN–H2O from 10% to
50% MeCN in 40 min (method a) and MeCN–H2O (0.1% TFA in
H2O), 30% to 75% MeCN in 35 min (method b) was used. Pure 1a
and 2a were obtained from the CH2Cl2 and ethyl acetate extracts
at Rt 13.0 min (method a) and Rt 16.0 min (method b), respectively.
The pure products 1a and 2a were analyzed by NMR and HRESIMS.
Compounds obtained from 12C/18O double-labelling experiments
were methylated using an ethereal solution of [13C]diazomethane,
which was prepared from N-[13C]methyl-N-nitroso-p-toluenesul-
fonamide using a standard procedure. Semipreparative HPLC on a
[2,5,6-tri-O13CH3]2,5,6-Trimethoxy-7-phenylphenalen-1-one
(2b, Rt 13.8 min): HPLC (gradient d): Rt 13.8 min, UV (MeCN–H2O)
kmax 208, 279, 373 nm; 1H NMR (500 MHz, acetone-d6): d 3.27 (s,
1JHÀC = 144.7 Hz, 3H, 6-O13CH3), 3.93 (s, JHÀC = 144.5 Hz, 3H, 2-
1
O13CH3), 4.03 (s, JHÀC = 144.6 Hz, 3H, 5-O13CH3), 7.22 (s, 1H, H-
1
3), 7.39-7.47 (br, 5H, H-2’ to H-6’), 7.56 (d, J = 7.5 Hz, 1H, H-8),
7.86 (s, 1H, H-4), 8.49 (d, J = 8.5 Hz, 1H, H-9); 13C NMR (125 MHz,
acetone-d6):
(6-18O13CH3, 1D
d
55.7 (2-16O13CH3), 57.2 (5-16O13CH3), 60.64
d
LiChrospher RP18 column (5
l
m, 250 Â 10 mm) was used to purify
18O(13C)=À28 ppb), 60.67 (6-16O13CH3), 114.1
the O-methyl derivatives 1b and 2b. Method c: linear gradient
MeCN–H2O (0.1% TFA) from 40% to 60% MeCN in 20 min and meth-
od d: linear gradient MeCN–H2O (0.1% TFA) from 40% to 75% MeCN
in 30 min were used. Pure 1b was obtained with method c at Rt
15.7 min and two O-methyl derivatives 2b with method d at Rt
13.4 and 13.8 min.
(C-3), 119.9 (C-4), 121.9 (C-9b), 125.9 (C-3a), 127.2 (C-9a), 127.4
(C-4’), 127.8 (C-3’/C-5’), 128.2 (C-9), 129.3 (C-2’/C-6’), 129.9 (C-
6a), 131.3 (C-8), 144.7 (C-1’), 146.9 (C-7), 146.6 (C-6), 151.5 (C-
5), 153.4 (C-2), 179.6 (C-1). Please note different carbon atom
numbering in the text and figures.
[2,5,6-tri-O13CH3]2,5,6-Trimethoxy-9-phenylphenalen-1-one
(2b, Rt 13.4 min): HPLC (gradient d): UV (MeCN–H2O) kmax 209,
5.8. Analytical data of biosynthetic products and their O-methyl
derivatives
277, 374 nm; 1H NMR (500 MHz, acetone-d6):
d
3.84 (s,
1JHÀC = 144.5 Hz, 3H, 2-O13CH3), 4.10 (s, JHÀC = 144.8 Hz, 3H, 6-
1
O13CH3), 4.11 (s, JHÀC = 144.7 Hz, 3H, 5-O13CH3), 7.12 (s, 1H, H-
1
6-O-[(6’’-O-Allophanyl)-b-
D
-glucopyranosyl]-2,5-dihydroxy-7-
3), 7.34 - 7.45 (br, 5H, H-2’ to H-6’), 7.56 (d, J = 8.5 Hz, 1H, H-8),
phenylphenalen-1-one (1a): HPLC (method a): UV (MeCN–H2O)
kmax 211, 279, 378, 477 nm; 1H NMR (500 MHz, MeOH-d4): d
2.36 (dd, J = 7.9, 9.0 Hz, 1H, H-2’’), 3.04 (dd, J = 9.0, 9.3 Hz, 1H,
H-4’’), 3.09 (ddd, J = 2.2, 6.5, 9.0 Hz, 1H, H-5’’), 3.19 (dd, J = 9.0,
9.3 Hz, 1H, H-3’’), 3.96 (dd, J = 2.2, 11.8 Hz, 1H, H-6’’b), 4.18 (dd,
J = 6.5, 11.8 Hz, 1H, H-6’’a), 4.67 (d, J = 7.9 Hz, 1H, H-1’’), 7.04 (s,
1H, H-3), 7.22 (br, 1H, H-5’), 7.33 (br, 2H, H-4’, H-2’’), 7.39 (br,
1H, H-6’), 7.43 (br, 1H, H-3’), 7.46 (s, 1H, H-4), 7.54 (d,
J = 7.6 Hz, 1H, H-8), 8.47 (d, J = 7.6 Hz, 1H, H-9); 13C NMR
(125 MHz, MeOH-d4): d 64.9 (C-6’’), 71.1 (C-4’’), 74.6 (C-2’’),
75.2 (C-5’’), 77.6 (C-3’’), 104.1 (C-1’’) 116.3 (C-3), 121.7 (C-9b),
124.2 (C-4), 127.3 (C-2’), 127.8 (C-6ª, C-4’) 128.3 (C-6’), 128.5
(C-3a), 128.6 (C-9), 130.0 (C-9a), 130.7 (C-3’), 131.8 (C-5’), 132.3
7.82 (s, 1H, H-4), 8.52 (d, J = 8.5 Hz, 1H, H-7); 13C NMR (125 MHz,
acetone-d6):
d
55.8 (2-16O13CH3), 57.24 (5-18O13CH3, 1D
d
18O(13C)=–28 ppb), 57.27 (5-16O13CH3), 61.9 (6-16O13CH3), 112.2
(C-3), 119.6 (C-4), 121.9 (C-6b), 126.3 (C-3a), 127.5 (C-4’), 128.4
(C-7), 128.6 (C-6a), 128.8 (C-3’/C-5’), 129.0 (C-2’/C-6’), 129.9
(C-9a), 132.2 (C-8), 144.3 (C-1’), 144.8 (C-6), 145.8 (C-5), 146.5
(C-9), 153.9 (C-2), 179.8 (C-1).
Acknowledgments
The authors thank the Deutsche Forschungsgemeinschaft for
financial support, and Emily Wheeler for editorial assistance.